UK genome analysis has important implications for COVID-19 clinical trials
Scientists at the University of Bristol who have been sequencing the genetic material from SARS-CoV-2 — the virus that causes COVID-19 — have highlighted important implications for scientists around the world conducting vaccine trials aimed at preventing the disease. The findings are published on the preprint site bioRxiv and peer review journal Genome Medicine.
